Moderna's Stock Soars Amid Bird-Flu Vaccine Efforts
Moderna's stock rises as it develops a bird-flu vaccine following a U.S. death. Stay updated on vaccine advancements and stock movements.
Moderna's stock surge is linked to its development of a bird-flu vaccine following a death in the U.S.